Veracyte, Inc. (VCYT)
NASDAQ: VCYT · Real-Time Price · USD
35.11
+0.50 (1.44%)
At close: Oct 8, 2025, 4:00 PM EDT
35.10
-0.01 (-0.03%)
After-hours: Oct 8, 2025, 4:00 PM EDT
Veracyte Market Cap
Veracyte has a market cap or net worth of $2.76 billion as of October 8, 2025. Its market cap has increased by 3.24% in one year.
Market Cap
2.76B
Enterprise Value
2.51B
1-Year Change
3.24%
Ranking
Category
Stock Price
$35.11
Market Cap Chart
Since October 30, 2013, Veracyte's market cap has increased from $274.10M to $2.76B, an increase of 907.72%. That is a compound annual growth rate of 21.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 2.72B | -11.28% |
| Dec 31, 2024 | 3.07B | 52.74% |
| Dec 29, 2023 | 2.01B | 18.01% |
| Dec 30, 2022 | 1.70B | -41.83% |
| Dec 31, 2021 | 2.93B | 3.30% |
| Dec 31, 2020 | 2.83B | 107.80% |
| Dec 31, 2019 | 1.36B | 167.37% |
| Dec 31, 2018 | 510.00M | 129.42% |
| Dec 29, 2017 | 222.30M | 2.77% |
| Dec 30, 2016 | 216.30M | 8.58% |
| Dec 31, 2015 | 199.20M | -8.37% |
| Dec 31, 2014 | 217.40M | -28.72% |
| Dec 31, 2013 | 305.00M | 11.27% |
| Oct 30, 2013 | 274.10M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |